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The study of heart rate variability, and especially the phenomenon 
of respiratory sinus arrhythmia, has contributed much to the understanding 
of cardiovascular reflexes in the past 100 years (17). The sinus node 
is not a simple pacemaker, but a complex structure that reacts to many 
kinds of influences via circulating catecholamines and its rich autonomic 
innervation. Consequently, in healthy human beings, the heart rate is 
not invariably fixed as occurs in some ectopic and in nodal rhythms, but 
demonstrates a delicate response to physiological events and manifests a 
sometimes remarkable variation in RR interval length from beat to beat. 
The irregularities of sinus rhythm mirror the fine adjustments of auto¬ 
nomic control for the entire cardiovascular system. 
The measurement of heart rate variability, a simple procedure, may 
offer clinical information that is not easily available otherwise. 
Though variability is influenced by respiratory patterns, it does not 
co-vary consistently with any of the easily measured physiological 
parameters. As it is influenced by many different processes, it may 
provide a nonspecific index of states of health and disease. Certainly 
it has been very useful in monitoring the condition of the fetus during 
pregnancy and labor (18, 41) and in monitoring clinically unstable 
neonates (24). Recent research has suggested that measurement of vari¬ 




denervation in diabetic autonomic neuropathy (3, 43), as a monitor of 
increased intracranial pressure in the acutely brain-damaged or in 
patients with chronic shunts for diversion of cerebral-spinal fluid (30), 
and as a screening test for sleep-apnea syndrome (40). Investigators in 
this field, however, have been inconsistent in their terminology and in 
their methods of quantifying variability, and research in the clinical 
application of variability measurement in adults has lagged behind the 
obstetric and pediatric literature. 
The goals of the present study are: 
1. To develop reproducible techniques for evaluating variability. 
2. To observe the patterns of variability which occur in normal 
adults at rest, during exercise, and during breathing maneuvers. 
3. To establish whether diminished variability consistently occurs 
in diverse pathological states in adults, as it does in the fetus and 
infant. 
4. To determine whether, in a few selected situations, the amount 
of variability correlates with severity of illness. 

REVIEW OF THE LITERATURE 
Characteristics of Normal Variability 
The two highest frequency types of heart rate changes are termed 
in the obstetrical and pediatric literature "short-" and "long-term" 
variability. Short term (beat-to-beat) variability can be expressed 
as the average difference in length between one RR interval and the one 
adjacent. Long term variability is a rhythmic change superimposed on 
the short term changes. It appears as phasic variations of 3-20 cycles/ 
minute and usually corresponds to major extracardiac events affecting 
the heart rate which can be observed over time. For example, uterine 
contractions produce characteristic synchronous patterns of relative 
bradycardia and recovery in the compromised fetus (39). In the neonate 
long term variability patterns are greatly influenced by respiratory 
events (24), while in the adult, long term variability generally can be 
considered synonymous with respiratory sinus arrhythmia. 
Changes in heart rate of still lower frequency have been observed. 
Simons and Johnson described a "cardioaccelerator waveform" appearing in 
normal subjects at low heart rates, especially while sleeping, which is 
5-10 times longer in duration than a respiratory cycle and is associated 
with disturbances in the EEG (38). Manzotti noted a "background noise" 




Furthermore, variability itself can vary in cycles. Under normal 
conditions, a cycle occurs with a 90-110 minute period while awake or a 
38-176 minute period while asleep, during which heart rate variability 
itself varies in degree (30). There is also a diurnal variation: the 
same investigators found an absence of variability in heart rate traces 
recorded during periods of sleep in all patients studied except those 
with profound brain damage. In addition, 40-second periods of sinusoidal 
variation in short term variability were seen in certain normal adults 
subjected to a cold pressor test (44). 
The normal amplitude of variability is difficult to determine, 
given that almost every study has employed a different method of defining 
and quantifying variability; some used no statistical analysis at all (8, 
29, 46 for discussions of analytical methods). 
Quantification of short term variability has been uncommon in clini¬ 
cal literature (14, 15, 27), while in the psycho-physiological literature 
statistical modifications of the raw data have prevented its usefulness 
for comparison with our work (10, 36, 44). Two studies, however, have 
provided some information as to the normal range. In a computer analysis 
of 260 adults, the maximum acceleration from one beat to the next during 
10-second cardiograms were recorded. Over 90% of the subjects had changes 
within +_ 6% of the initial RR interval length. Mean short term variability 
was not calculated; no relation was found between variability and heart 
rate (27). Another group used the ratio which we have adopted as "STVi" 
(mean beat-to-beat variation/mean RR interval) and found an average normal 
variability of 4.5% in 28 young adults (15). 
Respiratory sinus arrhythmia consistently exhibits certain morpho¬ 
logical characteristics. Usually there is a biphasic heart rate response. 
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acceleration-deceleration, for every respiratory cycle. Inspiration 
has far greater influence on heart rate than expiration, but either 
event can independently produce the biphasic response. The lag between 
onset of inspiration and the peak of cardioacceleration is constant 
regardless of the respiratory rate. At the usual respiratory rate of 
about 10/minute, acceleration occurs during inspiration and deceleration 
during expiration. The greatest amplitude of arrhythmia occurs at a 
rate of 5-6 breaths/minute, as it produces the most favorable "phase 
angle" (2, 11). The arrhythmia damps out at respiratory rates greater 
than 15 per minute (12). Clearly the amplitude of arrhythmia depends 
largely on respiratory rate. In one study amplitude and respiratory 
cycle length were not related on a one-to-one basis, but the mean ampli¬ 
tude of arrhythmia correlated with the mean respiratory cycle length (7). 
Amplitude is independent of mean heart rate (7, 27). 
The normal range of amplitude of respiratory arrhythmia is wider 
than for short term variability: large inter- and intra-subject differ¬ 
ences were seen in healthy adults, with a range of 2-40 beats/minute in 
cycle amplitude (7). In the analysis of 10-second cardiograms cited 
earlier (27) an indirect measure of respiratory arrhythmia, RRmax/RRmin, 
was found to be less than 1.17 in 98% of the tracings; no mean values 
were provided. In 14 men aged 21-39, mean LTVi (mean amplitude of 
respiratory arrhythmia/mean heart rate) was 27.1%, whereas in 10 men 
aged 40-65 it averaged 10% (21). Several others have also reported this 
inverse association between age and amplitude of respiratory sinus 
arrhythmia (17, 43), although Vallbona (43) also noted that elderly 
subjects occasionally have a marked long term variability that is not 
associated with the respiratory pattern. Of interest is the observation 
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of increasing variability with maturity in the fetus and infant (4, 46). 
Certain respiratory maneuvers exaggerate the amplitude of respira¬ 
tory arrhythmia. An abrupt sinus slowing occurs with sighing, coughing, 
or straining in healthy young adults (22). The deeper the breath the 
greater the inspiratory tachycardia in anesthetized dogs (34), and in 
humans Manzotti found that the increased depth and rate of breathing 
following exercise was associated with more pronounced respiratory 
arrhythmia (31). In view of the preceding information it is not sur¬ 
prising that respiratory arrhythmia can be maximized by "square wave" 
breathing, which is simply a technique of slow, deep breathing: rapid 
maximal inspiration, hold 5 seconds, rapid maximal expiration, hold 5 
seconds, etc. 
It should be pointed out that not every cyclic heart rate change 
termed "long term variability" is associated with breathing cycles. In 
neonates, although long term variability is altered by changes in breath¬ 
ing pattern, the heart rate cycles occur at a much lower frequency than 
the respiratory rate, with two to three inspirations for every cardio- 
acceleration (24). Among adults some observers have seen arrhythmia 
cycle through periods of apnea (38). In our observations and those of 
others (11, 31) cyclic arrhythmia disappeared during voluntary apnea, 
but Vallbona (43) observed, as did we, several instances of long term 
variability that was of a different frequency and out of phase with 
respirations. 
Physiology of Heart Rate Variability 
Heart rate is set by a network of reflex arcs whose final common 
effectors are the autonomic nerves and the sinus node itself. The 
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cardioregulatory center in the medulla is a primary regulator of heart 
rate, via the vagi and the cardiac sympathetic nerves. It is in turn 
influenced by cortical impulses, and by afferent impulses from the 
baroreceptors and atrial stretch receptors (the Bainbridge reflex) which 
route through the medulla. It has also been postulated that impulses 
generated by the medullary respiratory centers (21) and from pulmonary 
stretch receptors (the Hering reflex) influence cardiac rate. In addi¬ 
tion the sinus node itself responds to circulating factors and has an 
intrinsic rate of depolarization. The resultant cardiac depolarization 
ultimately depends upon normal refractoriness of the conduction system. 
The clearest synthesis of all theories of rate regulation in 
respiratory sinus arrhythmia has been provided by Freyschuss and Melcher 
(17) based upon an ingenious series of experiments on 31 healthy young 
men. Using externally assisted ventilation with a cuirass, a neck 
pressure cuff, positive and negative inspiratory pressure, standardized 
respiratory patterns, and gauges for measuring intraesophageal, right 
heart, and intra-arterial pressures, they were able to control separately 
for nearly every variable that has been postulated to be responsible for 
respiratory sinus arrhythmia. They found that the arrhythmia results 
from an integration of afferent inflow from systemic arterial baro¬ 
receptors, the low-pressure receptors in the heart, and possibly stretch 
receptors in the lung, according to the following schema. 
The intrathoracic pressure changes accompanying inspiration increase 
right heart filling pressure, which in turn causes an inhibition of the 
arterial baroreflex (it is "given a higher set point"). Consequently, 
during inspiration the baroreceptors are less responsive to a given 
arterial blood pressure, and heart rate rises. Freyschuss and Melcher 
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found a beat-by-beat correlation between right ventricular transmural 
filling pressure and cardiac frequency, and other workers (26) have, in 
fact, found vagal efferent activity to change with the respiratory cycle, 
ceasing during inspiration, just as this model would predict. 
These authors also felt that lung and/or thoracic wall stretch 
receptors may contribute to the deceleration during early expiration, 
but not to acceleration, the major component, because opposite patterns 
of rate change can be produced at the same lung volumes by manipulating 
inspiratory pressure. 
They found that the oscillation of systemic arterial pressure, 
previously postulated to produce respiratory arrhythmia (36), is itself 
a product of the arrhythmia. Ordinarily, if heart rate is driven by 
arterial pressure, a rise in pressure produces a drop in heart rate 
because of increased vagal output from baroreceptors. Instead, they 
found that heart rate rose concurrently with arterial pressure increases. 
Dependency on impulses generated from the medullary respiratory 
center was thought unlikely because the arrhythmia continued unchanged 
while subjects reported complete relaxation of respiratory effort with 
externally controlled ventilation. 
The conclusions of these authors provide an understanding of the 
physiological role of respiratory arrhythmia: the heart is allowed to 
increase cardiac output in response to cyclic changes in preload by 
increasing its rate, without counteraction by the systemic baroreflex. 
Nevertheless, the origin of the commonly-observed cycles of long term 
variability that are not related to respiratory cycles has yet to be 
explained. 
The vagus nerve conducts the most prominent influences on heart rate 
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variability of these cardioregulatory reflexes. The greater the vagal 
tone in dogs, the greater the amplitude of respiratory sinus arrhythmia 
(25, 43). Atropine in adults (11, 45) and vagal cooling in dogs (25) 
reduces the amplitude of respiratory arrhythmia, and atropine reduces 
short term variability in the fetus (23). In fact, the diminished vagal 
tone with age has been cited as an explanation for the reduction in 
amplitude of respiratory arrhythmia (45). 
Sympathetic tone, on the other hand, may be of secondary importance 
for variability, since propranolol lOmg IV failed to change the amplitude 
of respiratory sinus arrhythmia in 25 healthy adults (45). Diminished 
short term variability has been observed in some conditions associated 
with high circulating catechols or high sympathetic discharge and tachy¬ 
cardia, such as epinephrine administration and nociceptive stimuli in 
anesthetized dogs (10), but the commonly observed phenomenon of diminished 
long term variability during exercise (38) is probably attributable to 
high respiratory rates. 
The interpretation of variability in instantaneous heart rate 
recordings raises the question as to whether beat-to-beat and respiratory 
arrhythmia are actually two independent phenomena. Beat-to-beat changes 
could be considered the building blocks of long term variability. In 
fact, among our own sample, short term changes in RR interval are nearly 
always in the same direction as the long term changes: respiratory 
arrhythmia is accomplished in a series of one-way steps (Figure 1). 
Indeed, when the amplitude of respiratory arrhythmia is small and the 
respiratory rate is relatively quick, short and long term changes begin 
to merge. That short term and long term variability are to some degree 
independent, however, is demonstrated in Figure 2, a recording from one 
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of our subjects with diabetic dysautonomia who retained a small amount 
of beat-to-beat variation despite the total absence of long term vari¬ 
ability. Careful inspection of this tracing will reveal that the tiny 
fluctuations in heart rate are not synchronous with respiratory cycles, 
and the respiratory rate is not so high that one would expect "damping 
out" of respiratory arrhythmia. The small-amplitude short term 
variability in this recording is probably not electrical "noise," as 
tracings from some patients were seen that were virtually straight lines. 
Vallbona also described beat-to-beat variability in recordings lacking 
respiratory arrhythmia (42). The normal fetus in utero exhibits marked 
short term variability (46) while accomplishing only rudimentary respira¬ 
tory efforts. In our control sample, LTV amplitude but not STV correlated 
with respiratory rate. Short term variability, therefore, does not 
require the same set of conditions as does respiratory arrhythmia. 
Nevertheless, short term variability must be largely dominated by long 
term variability when the latter is present: if, for example, the ampli¬ 
tude of the cyclic arrhythmia is large, the variation from beat to beat 
will of necessity occur in large increments. 
Variability in Abnormal Conditions 
Any of the mediators of heart rate variability may be affected by 
conditions of disease or by drugs and consequently modify variability. 
Several situations in which variability is diminished or increased from 
normal are known. Diminished variability seems to be a sensitive but 
nonspecific sign of altered homeostatic control. 
(The terminology of references cited below has been translated, 
where possible, into the common set of definitions provided in the 
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Materials and Methods section of this paper.) 
1. Fetal and neonatal distress syndromes 
Diminished short term variability is associated with a number 
of pathological states in early life, including head compression and 
uteroplacental insufficiency during labor (2), respiratory distress 
syndrome and intracranial bleeding in neonates (21). It is the most 
consistently found abnormality in fetal heart rate traces of infants 
that later died intrapartum (18). In antepartum recordings low short 
term variability accompanied by abnormal long term variability in 
response to uterine contractions is a fairly reliable predictor of 
perinatal mortality of whatever cause (41). 
2. Sedative drugs 
Drugs administered to the laboring mother such as diazepam and 
phenobarbital diminish short term variability in the fetus (16). Morphine 
diminishes variability in the human fetus (46) but exaggerates it in the 
anesthetized dog (1, 43). Meperidine, alphaprodine, phenergan, and 
hydroxyzine all diminish variability in the fetus (35). 
3. Hypoxia 
Hypoxia and respiratory distress syndrome decrease variability in 
the fetus and newborn (46) and breathing 100% oxygen increases respiratory 
arrhythmia in adults (42). Freyschuss and Melcher (17) found no evidence 
for correlating respiratory arrhythmia with pC02. 
4. Central nervous system disease 
Vallbona (42) described several abnormal patterns of variability in 
102 adult patients with CNS disease compared to 40 healthy controls. 
Some of their patients lacked respiratory arrhythmia, but most of these 
retained detectable short term variability. 
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Patients with brain stem injury had patterns resembling neonatal 
heart rate traces, with paroxysms of brady- or tachycardia, correlating 
to the periods of apnea and breathing in those with periodic breathing. 
The authors attributed this appearance of the recording to loss of 
cortical inhibition on cardioregulatory centers, analogous to the 
paucity of transmitted cortical activity in the neonate. 
Quadriplegic patients had diminished respiratory arrhythmia at 
rest, which disappeared entirely in the tilt position even when postural 
hypotension was prevented with pressure suits. They also showed abnormal 
responses to the Valsalva maneuver. In contrast, the paraplegics showed 
normal variability and heart rate responses. These observations are 
consistent with Freyschuss and Melcher's formulation which depends upon 
a number of reflex arcs requiring intact cervical spinal cord to explain 
respiratory arrhythmia. 
The most striking recordings were obtained from eight patients in 
deep preterminal coma, who showed a complete absence of variability even 
in the presence of nociceptive stimuli. 
Lowensohn et_ afL. (30) found an interesting correlation between 
variability, intracranial pressure, and neurological function. In 10 
adults with acute-neurological deficits, none of whom were on drugs or 
hypoxic, short term variability was low, diminished as intracranial 
pressure rose, and returned to normal not with normal intracranial 
pressure but with return of neurological function. They suggest monitor¬ 
ing heart rate in neurological patients as an aid in assessing intracranial 
pressure changes. 
5. Diabetes mellitus 
RR interval histograms showed a narrower range of RR intervals, 
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implying diminished short and long term variability, in three patients 
with diabetic autonomic neuropathy (8); Lloyd-Mostin and Watkins (28) 
describe a 28-year old woman with extensive autonomic neuropathy whose 
heart rate was fixed and responded with less than four beats per minute 
change to deep breathing and other procedures designed to enhance 
sympathetic and parasympathetic activity. 
Wheeler and Watkins (45) found that low LTV (amplitude of respiratory 
arrhythmia) and low maxLTV (maximum amplitude of arrhythmia induced by 
slow, deep breathing) distinguished between diabetics who were clinically 
symptomatic with autonomic neuropathy and those who were not: nine of 
nine symptomatic patients had both low LTV and low maxLTV, while none of 
the 15 who were asymptomatic differed from controls in either type of 
variability. Short term variability was not measured. The symptomatic 
patients also manifested other signs of vagal dysfunction, as they all 
failed to raise their heart rates more than 20 beats per minute in 
response to 1.8 mg IV atropine, most had high resting heart rates, and 
most did not show the normal reflex bradycardia following Valsalva. 
Bennett et_ afL. (3) later confirmed this relationship of diminished 
variability and vagal dysfunction in diabetics. Of 21 patients, 13 had 
low variability as' defined by the mean amplitude of respiratory arrhythmia 
during deep breathing. The low variability did not correlate with age 
or heart rate. Eleven of these 13 had evidence of abnormal parasympathe¬ 
tic function by other tests (postural change, Valsalva, facial immersion 
in water, phenylephrine infusion), a finding which is consistent with the 
studies that relate variability primarily to parasympathetic tone (11, 
45). Among their subjects, four patterns of autonomic dysfunction were 
described, with parasympathetic impairment more common than sympathetic 
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impairment. These investigators speculated that diabetic dysautonomia 
progresses with time, affecting vagal nerves first, and that diminished 
variability might therefore provide an early test of dysautonomia. 
Since the authors did not state how many of the original group or how 
many of those manifesting low variability had clinical dysautonomia, 
one cannot determine from their data how consistently diminished vari¬ 
ability predicted autonomic neuropathy. Another study indicates that it 
may be extremely sensitive: Murray e_t ad^. (33) found markedly low 
variability using RR interval histograms in 42 diabetic young men with¬ 
out dysautonomia compared to 25 controls. The 13 patients with prolifera¬ 
tive retinopathy had the greatest decrease in variability. Although 
diabetics had higher heart rates than controls, variability was not 
dependent upon heart rate in either group. These results imply that 
diminished heart rate variability may be the earliest clinical sign of 
autonomic neuropathy, appearing before any symptoms of dysautonomia. 
The apparent disagreement between this group and Wheeler e_t a_l. (45) as 
to the presence of low variability in asymptomatic diabetics may be 
accounted for by the different methods of quantifying variability. The 
histogram method does not distinguish between short and long term 
variability. If both are low, the difference from controls using histo¬ 
grams would be amplified as compared to a method like Wheeler's that 
measures long term variability alone. 
6. Heart disease 
Surprisingly little attention has been paid to abnormalities of 
sinus arrhythmia in people with heart disease. 
Three of Heilman's (21) subjects reported having a history of heart 
disease of unspecified type. Of those, two had lower LTVi than would be 
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predicted for their ages, with the average of the group -22% of predicted 
value. The third had very high LTVi. 
In a seven-year prospective study of 301 middle aged men (22) the 
subpopulation with low variability on initial examination was found to 
have overt abnormalities of cardiac pacemakers or to develop them later 
more frequently than the rest of the population, and experienced signifi¬ 
cantly more sudden cardiac deaths. These men were said to have "sustained 
relative bradycardia" defined by the presence of all of the following 
characteristics: lack of diurnal variation in heart rate, low peak rate 
in response to exercise, low amplitude respiratory arrhythmia, and lack 
of abrupt sinus slowing with sighing, coughing, or straining. This low 
variability group was distinguished from the general population by a high 
incidence of cardiac and pulmonary illness: 12 of the 34 men had coronary 
artery disease, nearly twice as many as would be expected from random 
distribution. Three others had hypertension, four had chronic pulmonary 
disease, 11 had a combination of the three illnesses, leaving only 7 of 
the 34 free of cardiac, pulmonary, or hypertensive disease. By the end 
of the seven-year study period only one man was free of all of these 
diseases. Low variability was a moderately sensitive index of heart 
disease in general, as its incidence among subjects with "definite" 
coronary artery disease was 31% (9 of 29) compared to 9% (25 of 272) of 
the population as a whole. 
The authors postulated that the relative bradycardia and low 
variability in these patients was caused by sinus node disease, sometimes 
subclinical, which in later years progressed and predisposed the subjects 
to arrhythmic deaths. The low mean heart rates of their group, in con¬ 
trast to studies of diabetics (3, 33) where the low variability groups 
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had high heart rates, supports cheir hypothesis that low variability in 
these heart disease-prone patients was produced by intrinsic sinus node 
disease and not by impairment of vagal tone. Their patients did have a 
high incidence of abnormal p-waves on cardiograms, but they may also 
have had at least sympathetic dysfunction: other workers have found 
low parasympathetic (13) and sympathetic (19) tone in patients with 
various kinds of heart disease, based upon low responsiveness of the 
heart rate to atropine, to induced hypotension, and to induced hyper¬ 
tension. In neither of the latter two studies, however, were patients 
evaluated for the presence of sinus node pathology, which might prevent 
rate responses to normally adequate autonomic input. 
7. Hypertension 
There has been one study of variability in hypertension (14) , which 
compared 15 adults with hypertension (who had abstained from all medica¬ 
tions for two weeks) to 15 controls. Variability was measured as STV 
(mean difference between successive RR intervals) for 10 successive RR 
intervals, and was lower in the hypertensives. The degree of diminish- 
ment of variability correlated with duration of hypertension but not with 
mean blood pressure. 
8. "Poor health"* 
In a study of respiratory arrhythmia (21) four of five subjects who 
reported "poor general health" (not described more specifically by the 
authors) had lower LTVi (amplitude of respiratory arrhythmia/mean heart 
rate) than would be predicted for their ages. The mean deviation was 
-33% of the predicted value. These subjects were not hospitalized at the 
time of the recording. 
A period of two weeks of bed rest was found by Davies and Neilson 
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(12) to reduce the amplitude of post-exercise respiratory arrhythmia in 
one subject, and two weeks of exercise training restored the variability. 
But Heilman and Stacy (21) found that amplitude of respiratory arrhythmia 
at rest did not correlate with exercise habits in 24 adult men. 
9. Obesity 
Three of four subjects who were "significantly overweight" had lower 
LTVi than would be predicted for their ages, with a mean deviation of 
-29% of predicted value (21). 
10. Alcoholism 
There has been only one study of variability in alcoholics, which 
showed an increase in variability compared to controls when subjects were 
engaged in the task of reporting numbers presented to both ears. The 
alcoholics with histories of head trauma had lower variability than 
those without such a history (5). 
In summary, the literature to date on variability in illness docu¬ 
ments that: 
1. Diminished heart rate variability accompanies hypoxia and 
administration of certain drugs in the fetus and neonate, central nervous 
system disease in‘all age groups, autonomic neuropathy in diabetics, and 
heart disease. 
2. There is some scant evidence that diminished variability also 
accompanies obesity, alcoholism, hypertension, and "poor health" in 
general. 
3. Monitoring heart rate variability is of use in the clinical 
management of labor and in neonatal intensive care; it is of potential 
use in the management of increased intracranial pressure. 

A. Diminished variability may predict an increased risk for 
sudden cardiac death in middle aged men. 
>■ 
SUBJECT OF THE PRESENT INVESTIGATION 
This study constitutes a survey of beat-to-beat variability and 
respiratory sinus arrhythmia in 151 instantaneous heart rate recordings 
of 137 middle-aged and elderly men. Some techniques for measuring 
short and long term variability are evaluated, and used to search for 
trends in variability in a variety of clinical illnesses. Variability 
of each group of patients with the same illness is compared to that of 
healthy subjects. A number of heart rate recordings obtained during 
treadmill stress tests are also analyzed. 
19 

MATERIALS AND METHODS 
Equipment 
A neonatal physiologic monitor (Corometrics, Model 512) was modi¬ 
fied to process adult-voltage EGG complexes. The monitor measured and 
continuously plotted the length of each RR interval, displayed as 
instantaneous heart rate in beats per minute on heat-sensitive graph 
paper. A second channel recorded respiratory excursions by measuring 
respiratory-induced changes in impedance across the chest. The QRS 
complexes were continuously displayed on an oscilloscope screen. 
Corometrics engineers estimated the recording of heart rate to be 
accurate within less than two beats per minute, and the variability 
pulses to be accurate within .01 beat per minute. 
Patients and Controls at Rest 
1. Patient selection 
Patients with a primary problem of diabetes mellitus, heart disease, 
hypertension, or respiratory distress, and patients on peritoneal or 
hemodialysis for chronic renal failure on inpatient wards and outpatient 
clinics at the Veteran’s Administration Hospital, West Haven, Connecticut 
were studied. Patients suffering from more than one of the above condi¬ 




hospital charts, to be primarily responsible for the patient's symptoms. 
No patient was listed in more than one disease category. Analysis was 
performed on the data from all patients with a given disease and also 
on the subgroup who had only a single one of the diseases being studied. 
Patients with pathological arrhythmias at the time of recording 
such as frequent premature atrial or ventricular beats, atrial fibrilla¬ 
tion, or multifocal atrial tachycardia were excluded from analysis. The 
characteristics of the major illness, medications taken, and presence of 
other illness were also determined through patient interviews and chart 
review. The medications taken were classified into three groups (20): 
the first group included drugs thought to influence heart rate either 
directly or via reflexes stimulated by the drug; the second included 
drugs suspected but not known to influence heart rate, and the third 
included drugs for which no evidence is given for influence on autonomic 
function or heart rate (Figure 3). 
Control subjects were recruited from male hospital staff and from 
patients admitted for minor surgical procedures, all devoid of known 
systemic or cardiac illness. 
All patients and control subjects were male. 
2. Procedure 
After obtaining verbal informed consent, the skin was prepared and 
electrodes attached on the right arm, right and left anterior chest wall. 
When the recording stabilized and background "static" disappeared, the 
heat pen recorder was turned on. The patient was instructed to remain 
lying or seated quietly while the recorder was allowed to run continuously 
for 20 minutes or until the machine had registered a "variability pulse" 
(see below). Then the subject was asked to perform a respiratory maneuver 
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designed to maximize cyclic respiratory heart rate changes. In most 
cases the subject performed square wave breathing for a period of one 
to one-and-a-half minutes. Subjects were instructed not to Valsalva 
during square wave breathing. In some subjects timed reduction of 
respiratory rate to six per minute was performed instead of square wave 
breathing, or the magnitude of the maximal heart rate change during a 
spontaneous sigh or cough was recorded. A few patients early in the 
study performed no respiratory maneuvers at all, and most respiratory 
distress patients were unable to alter respiration due either to mechani¬ 
cal ventilation or to dyspnea. 
The subjects’ respiratory rates were counted over a period of one 
minute after the start of the recording. 
3. Interpretation of recordings 
a. Heart rate. The subjects' average heart rates over the entire 
period of recording were estimated to the nearest beat per minute. 
b. Short term variability. Short term (beat-to-beat) variability 
was categorized according to the appearance of the tracing as "low" or 
"average" (Figures 4 and 5). 
The monitor provided a quantitative measure of short term vari¬ 
ability by calculating the absolute value of the difference in length 
between one RR. interval and the next, averaged over 512 successive 
beats: 




After every 512 beats the heart rate trace was interrupted by a "vari¬ 
ability pulse" expressing this average difference in RR interval length 
Z 
x - 512 
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on a scale ranging from 0-42 milliseconds (earlier recordings) or 0-3.5 
beats per minute (later recordings). The variability pulse was not 
available for all subjects' recordings and was not expressed in the 
same units of measurement for all subjects because of interference with 
that function while respiratory monitoring capability was being installed 
in the machine. 
Occasionally it was felt that a subject had enough ectopy that the 
variability pulse was falsely high and did not represent the true vari¬ 
ability of the subject's sinus rhythm. In such cases the appearance of 
the short term variability during periods free of ectopy was scored, but 
the variability pulse was discarded from analysis (Figure 6). 
The variability pulse was read to the nearest millisecond or 0.25 
beat per minute. When the recording continued long enough for more than 
one variability pulse to register, the readings were averaged. 
c. Long term variability. The average cyclic change in heart rate 
associated with respirations was determined manually (Figure 1). 
The maximum change in heart rate associated with any respiratory 
maneuver was also scored (Figure 7). 
4. Data reduction 
All quantitative measurements were translated into equivalent units 
according to the following formulae: 
a. Short term variability in beats per minute to short term 
variability in milliseconds (STV): 
60,000 - 60,000 
----- —- = STV 
avg. heart rate + var. in bpm avg. heart rate 
b. Average cyclic change in heart rate to average cyclic change in 
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RR interval length in milliseconds (long term variability, or LTV): 
60,000 60,000 
-...- _ - = LTV 
avg. heart rate - i var. in bpm avg. heart rate + ± var. in bpm 
c. Maximum change in rate with respiration to maximum change in RR 
interval with respiration (maxLTV): equation exactly analogous to (b). 
Because of the possibility that heart rate variability varies with 
mean heart rate, each of the above three functions was also normalized 
for heart rate and expressed as an index according to the following 
formula: 
STV (or LTV or maxLTV) _ 
_ X 100 = STVi (or LTVi or max LTVx). 
60,000/avg. heart rate 
Stress Tests 
All patients referred for stress tests at the V. A. Hospital between 
February and June, 1977, had instantaneous heart rate recordings simul¬ 
taneously with their treadmill exercise tests. Information about these 
subjects included current medications, workload achieved on the treadmill, 
and outcome of the stress test. Analysis was limited to those subjects 
with clearly positive or negative stress tests according to the judgment 
of the attending cardiologist. 
The recordings were evaluated without knowledge of the outcome of 
the stress tests. They were scored for short term variability ("low," 
"average," or "high") and for long term variability during exercise and 
recovery. At the time of these recordings the monitor did not have the 




Statistical analyses were performed using the Student's two-tailed 




Appearance of Variability 
Compared to Automatic Calculation by the Monitor 
Manual analysis of the recordings provided a fairly reliable 
guide to short term variability. There was a modest correlation 
between the finding of "low" versus "average" variability and the 
measurement provided by the monitor's variability pulse (STV) in 81 
recordings of patients and controls (r = .64, p < .001). There was a 
similar correlation between the appearance of the tracing and the vari¬ 
ability pulse normalized for heart rate (STVi) (r = .65, p < .001). 
The correspondence between manual and automatic readings was far from 
absolute, however, as many examples occurred where the same value of 
STV or STVi appeared to be "average" variability in one tracing but 
"low" variability in another. 
Control Subjects 
Three of the 15 controls were preoperative hospital patients rather 
than healthy volunteers. Their diagnoses included degenerative joint 
disease, benign prostatic hypertrophy, and cataracts. They had no other 
systemic illness and took no medications affecting cardiac autonomic 
function with the exception of the subject who took imipramine 25 mg 




The control subjects ranged in age from 30 to 83 with an average 
age of 49. Their respiratory rates averaged 14.5 per minute. Their 
heart rates ranged from 63 to 105 with an average of 82. 
Three control recordings had an appearance of "low" variability. 
The group as a whole exhibited STV averaging 25 msec and STVi of 3.2%. 
On three of the recordings the variability pulse hit the upper limit of 
the scale. They were each scored as 42 msec, but the true average short 
term variability was probably higher than the numbers given here. 
LTV in the controls averaged 8 beats per minute per cycle, producing 
an average LTVi of 10.1%. 
All control subjects performed square wave breathing, which usually 
produced a pattern of gradual cardioacceleration during inspiration and 
a rapid deceleration as the breath was held. Occasionally during the 
expiratory phase the pattern repeated but with smaller amplitude, as is 
well illustrated in Figure 7. The average maximum heart rate change was 
34 beats per minute and 42% maxLTVi. 
All of the measurements of variability were tested for correlation 
with subjects' ages, heart rates, and respiratory rates. None correlated 
with age, but STV varied inversely with heart rate (r =-.71, p < .01), 
maxLTV showed a weak inverse correlation with heart rate (r = -.57, 
p < .05), and LTVi shoxved a weak inverse correlation with respiratory 
rate (r = -.56, p K. .05). We did not find that LTV invariably "damped 
out" at the higher respiratory rates. It is possible that short term 
variability also varied with respiration but that the range of respiratory 
rates among control subjects (10-19 per minute) was too small to demon¬ 




All of our patient groups manifested low heart rate variability 
compared to controls. Figure 8 tabulates the group means, standard errors 
of the mean (SEM), and results of t-testing or chi-square for the patient 
group recordings compared to controls. 
1.a. All diabetics 
The characteristics of the 15 subjects with diabetes mellitus are 
summarized in Figure 9. Most of the patients volunteered from clinics, 
but a few had been admitted to hospital for elective surgery or for non¬ 
life threatening complications of diabetes. This was a heterogeneous 
group, with patients having suffered from diabetes from a few years to more 
than 20, requiring only diet control to more than 80 units of NPH insulin 
per day, and having a variety of other illnesses along with the diabetes. 
Patients who reported postural hypotension, chronic diarrhea, or non- 
situational impotence were listed as having "dysautonomia" when other 
causes for their symptoms had not been proven. None of the patients 
reported other symptoms of dysautonomia. A high proportion (10 of 15) 
reported symptoms of peripheral motor/sensory neuropathy. Four patients 
had both atherosclerotic heart disease and hypertension. Seven patients 
(47%) were taking drugs with possible autonomic actions (group 1 or 2 
drugs) and 11 (73%) were taking other medications (group 3 drugs) as well. 
These subjects averaged 57 years of age, 17 breaths per minute, and 
85 bpm heart rate. The respiratory rate was higher than controls (p < .05). 
The diabetic recordings exhibited lower short term variability than 
controls, with STV of 10.5 msec and STVi of 1.3% (both p < .01, N = 13). 
The proportion of recordings with "low" variability was higher than 
controls (11 of 15, 73%, p < .025). 
Long term variability was also lower than controls: LTV 4 bpm and 
LTVi 4.9% (both p < .01). 
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Eleven of these subjects performed square wave breathing, which 
elicited maximum-long term variability lower than controls: maxLTV 
18bpm; maxLTVi 23% (both p < .01). Additional data from four patients 
who performed other respiratory maneuvers (sighing, reduced respiratory 
rate) brought the average down slightly: maxLTV 16bpm; maxLTVi 19.9% 
(both p 4 . 001) . 
Patients with symptoms of dysautonomia (N = 6) showed much lower 
variability than patients without such symptoms (N = 9), despite the 
high incidence of peripheral motor/sensory neuropathies in the latter 
group (5 of 9) (Figure 10). STV was 5 msec in symptomatic versus 15 msec 
in asymptomatic patients (p .02); STVi was 0.7% versus 1.9% (p < .02); 
LTV was 1.5bpm versus 6bpm (p < .025); and LTVi was 1.6% versus 7.1% 
(p •£ .02). The two groups did not differ at the 5% confidence level in 
maxLTV or maxLTVi. STV and STVi remained significantly lower than 
controls even among diabetics without symptoms of dysautonomia. 
Variability (STVi) did not correlate with number of years of clini¬ 
cal diabetes (r = -.04, p ^ .10). 
1.b. Subjects with diabetes only 
Six of the 10 patients in this group did have other illnesses, 
although not ones -known to interfere with autonomic function (unstarred 
diseases in Figure 9). Two (20%) patients were taking drugs with auto¬ 
nomic actions. 
These subjects had the same average age, respiratory and heart rates 
as the total diabetes group, but the smaller sample size caused the 
difference in respiratory rate from controls to lose significance 
(p 4 .10). 
Their short term variability as measured by the monitor (N = 9) was 
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also lower than controls: STV 13 msec (p < .02), STVi 1.7% (p ^ .005). 
The proportion of recordings with "low" variability was higher than 
controls but did not reach the 5% level of confidence (6 of 10, p > .10). 
Long term variability in these subjects was only slightly less 
than controls: LTV of 5 bpm and LTVi of 6.3% (p ^ .10). 
The variability produced by respiratory maneuvers in these subjects 
approximated that in the diabetes group as a whole, and was less than 
controls. For those who performed square wave breathing (N = 9), maxLTV 
was 20.5 bpm (p .02), maxLTVi was 26.7% (p < .05); adding data from 
the one patient who performed a different maneuver: maxLTV was 21.3 bpm 
(p C .02) and maxLTVi was 27.7% (p £ .05). 
2.a. All heart disease patients 
The heart disease group was also heterogeneous (Figure 11), though 
the majority suffered from arteriosclerotic coronary vascular disease. 
They were somewhat sicker as a group than the diabetics, with 10 of the 
19 in hospital because of cardiac disease. As to be expected in this 
group, most (18 of 19, 95%) were taking drugs with possible autonomic 
actions and an equal number were taking other drugs as well. Of parti¬ 
cular note are the five patients who were taking antiarrhythmic medication. 
These subjects had an average age of 53. The average respiratory 
rate of 20 was faster than controls (p 4, .001). The average heart rate 
of 71 was marginally lower than controls (p ^ .10), probably related to 
the high proportion of propranolol users. 
The heart disease patients had lower short term variability than 
controls as expressed by STVi (2.2%, p < .02), but STV did not differ as 
much (19.5 msec, p <£ .10). The proportion of patients with "low" 
variability approximated that of the control group (7 of 19, p > .10). 
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Long term variability in these patients was low: LTV 3 bpm, LTVi 
4.3% (both p < .001). 
All 19 subjects performed square wave breathing which again elici¬ 
ted maximum-long term variability lower than controls: maxLTV 15 bpm, 
maxLTVi 21.6% (both p ^ .001). 
There was a suggestion of a relationship between variability and 
functional class (Figure 10). Class I and II patients (N = 7) had higher 
maxLTV than class III and IV patients (N = 12): 22 bpm versus 11 bpm 
(p < .025). But when maxLTV was normalized for heart rates the two 
groups were less well differentiated: 28.8% versus 17.4% (p < .10). 
2.b. Subjects with only atherosclerotic heart disease 
These patients had heart disease with atherosclerosis as the only 
known cause, and included subjects with angina, history of or recent 
myocardial infarction, and/or congestive heart failure. Three of the 
eight (37.5%) also had other illnesses not known to interfere with 
autonomic function (unstarred list in Figure 11). All of them, however, 
were taking drugs with autonomic actions. 
These subjects had the same average age as the total heart disease 
group, but their average respiratory state was closer to that of con¬ 
trols (18, p “C .10 compared to controls) and their heart rates averaged 
still lower than the group as a whole (60, p .001 compared to controls). 
Their short term variability was similar to that of controls: STV 
26.6 msec and STVi 2.6% (both p .10); the proportion with "low" vari¬ 
ability was three of eight (37.5%, p > .10). 
Long term variability in this group, on the other hand, was low: 
LTV 3 (p < .001), LTVi 4.5% (p < .01). 
Maximum long term variability was the most distinct from controls: 
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maxLTV 13 bpm, maxLTVi 21.6% (both p .001). 
3.a. All hypertension patients 
The 13 hypertension patients were studied during clinic visits. 
Figure 12 summarizes the extent of hypertensive disease and associated 
illness in this group. The average blood pressure readings were not 
recorded since most patients were being treated to achieve normal 
pressures; instead, the duration of hypertension and of treatment were 
noted as indices of the length of time the subject had been exposed to 
abnormal arterial pressures. Those subjects in the "intermittent" 
treatment duration group included patients who were treated intermit¬ 
tently, incompletely, or in whom a lag of a year or more occurred 
between diagnosis and treatment. Eight of the 13 subjects (61.5%) were 
taking drugs with possible autonomic actions, and seven (54%) took other 
drugs as well. 
These subjects were older than controls, with an average age of 60 
(p K .05) and breathed faster than controls, 18 per minute (p *4 .01). 
Their average heart rate was similar to that of controls, 77 (p > .10). 
All measurements of variability in this group averaged less than 
controls: 
For the 10 recordings with a variability pulse, STV averaged 9.75 
msec and STVi 1.4% (both p ^ .01). A higher proportion of these record¬ 
ings showed "low" variability than controls, 9 of 13 or 69% (p <? .025). 
LTV averaged 4 bpm, with an LTVi of 5.5% (both p <C .01). 
Only five of these subjects performed square wave breathing, which 
produced an average maxLTV of 22 bpm (p < .05) and maxLTVi 3J.7% (p C.10). 
Adding data from seven patients performing other respiratory maneuvers 
diminished the average maxLTV to 14.5 bpm (p < .01) and maxLTVi to 20.1% 
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(p < .001). 
Variability among the hypertensive patients was not related to 
duration of treatment, to duration of hypertension, or to degree of 
retinopathy. The subjects were divided into paired groups: those who 
had never received antihypertensive treatment (N = 6) versus those who 
had (N = 7); those with known hypertension for ^ 5 years (N = 6) versus 
>5 years (N = 6); those with Grade 0 or I retinopathy (N = 3) versus 
Grade II or III (N = 5). None of these pairs differed from each other 
even at the 10% level of confidence for any measure of variability. 
3. b. Subjects with only hypertension 
Three of the eight patients in this group had other illnesses which 
are listed in Figure 12. Four (50%) took drugs with possible autonomic 
actions. 
Their ages, respiratory rates and heart rates approximated those of 
the group as a whole, as did their pattern of low variability. 
For the six recordings with a variability pulse STV averaged 5.25 
msec and STVi 0.7% (both p 4 .001). Seven of the eight recordings (87.5%) 
exhibited "low" variability (p < .01). 
LTV averaged 4 bpm (p < .02) and LTVi 4.9% (p < .01). 
Only one subject performed square wave breathing, but six others 
performed other maneuvers which produced an average maxLTV of 13 bpm and 
maxLTVi 16.9% (both p < .001). 
4. a. All respiratory distress patients 
These patients were the most seriously ill in the study, with six 
of the eight hospitalized for treatment of pulmonary disease. Most were 
moderately hypoxic, with p02 less than 80 mm Hg. Several conditions 
contributed to the respiratory failure of one extremely ill patient who 
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also carried a number of other diagnoses; he is indicated by the + marks 
in Figure 13. Every one of these subjects was taking drugs with possible 
autonomic actions. 
Several of the patients were under controlled mechanical ventilation. 
The average respiratory rate was 18 (p < .10). The heart rates were high, 
averaging 103 (p < .005), but the ages did not differ significantly from 
controls (57, p ^ .10). 
These recordings exhibited diminished short term variability, STV 
averaging 5.5 msec and STVi of 0.9% (both p < .001). They all appeared, 
by visual assessment, to have "low" variability (8 of 8, p ^ .005). 
Long term variability was also low, averaging 2 bpm (p < .005) and 
LTVi of 2.4% (p < .001). 
Six patients were studied with different levels of arterial p02, 
with an average change per subject of 28 mm Hg. In only one, the patient 
who was studied over the widest range of p02, was any correlation 
observed between p02 and variability. In this patient the tracing at a 
p02 of 53 showed "low" variability, STV of 7.5 msec or STVi of 1.1%, and 
no long term variability at all. The recording at a p02 of 104 showed 
"average" variability, STV of 14.5 msec or STVi of 2.2%, and an average 
cyclic long term variability of 10 bpm. 
The subject with sleep apnea syndrome displayed variability that 
was no different while asleep than that while awake despite documentation 
of 20-30 second apneic periods during sleep. He was slightly more hypoxic 
asleep than awake (p02 47 vs. p02 65). 
The strikingly "flat" appearance of some of the tracings in this 
group raised the possibility that mechanical ventilation suppresses heart 
rate variability, so we examined the recordings from one patient who was 
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studied both on the respirator and later, breathing independently. 
This man's flattest tracing was recorded while on completely controlled 
ventilation. The recording on intermittant mandatory ventilation of 
six per minute with a net respiratory rate of 18 showed more long term 
variability than recordings obtained while he was breathing on his own 
with respiratory rates of 25. The amplitude of long term variability 
in this man seemed to depend, therefore, on an optimum self-initiated 
respiratory rate rather than on use of the respirator (see Discussion). 
4 .b. Subjects with only respiratory distress 
Two respiratory distress patients had acute decompensation of 
chronic obstructive, pulmonary disease without other complications or 
illnesses. 
Those patients both had high respiratory rates, average of 20 
(p C.02) but their ages and heart rates did not differ significantly 
from controls. 
They showed low short term variability: STV 2.75 msec (p < .02) 
and STVi 0.5% (p < .01) but the sample was too small for the proportion 
with "low" variability (2 of 2) to attain significance at the 5% confi¬ 
dence level. 
Long term variability was also lower than controls, but it, too, 
failed to reach the 5% level of confidence: 6.5 bpm and 6.6% (both 
p ? .10). 
5.a. All dialysis patients 
The characteristics of these patients are summarized in Figure 14. 
All 18 were chronic renal failure patients who had been on dialysis for 
at least one month. One was then being hospitalized for work-up of fever 
and pericardial friction rub, that later resolved with no treatment 
. 
36 
other than dialysis, and the rest were stable outpatients coining in for 
one of their thrice-weekly treatments. The recordings were made during 
the dialysis. Hemodialysis took place over six hours for all patients, 
and two of the 18 were peritoneally dialyzed. In addition to the 
associated diseases listed in the table, they all had anemia and osteo¬ 
dystrophy because of the renal failure. Twelve of the 18 (67%) took 
possible autonomic-active drugs, and they all took other kinds of drugs 
as well. 
They did not differ from controls in terms of age (51), respiratory 
rate (17), or heart rate (87). 
These recordings displayed low variability of every type: STV 
averaged 9 msec, STVi was 1.2% (both p ^ .001). Fifteen of 18 or 83% 
showed ’’low" variability (p 4 .005). 
LTV averaged 3 bpm and LTVi 3.8% (both p <C .001). 
One patient could not understand instructions for respiratory 
maneuvers because of organic brain syndrome, but the remaining 17 sub¬ 
jects performed square wave breathing which elicited a low maximal-long 
term variability: maxLTV averaging 15.5 bpm (p «£ .001) and maxLTVi 
averaging 18.5% (p ^ .001). 
To test the hypothesis that diminished variability correlates with 
degree of uremia, recordings that were made within the first two hours 
of dialysis were compared to recordings made within the last two hours 
of dialysis. No difference appeared in any measure of variability 
between these two groups. 
Variability as expressed by STVi was not related to number of years 
of dialysis-requirement (r = -.02, p > .10). 
5.b. Patients with only chronic renal failure 
" 
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Only four of the 18 dialysis patients had neither hypertension nor 
heart disease of any kind. Three of these four did have other illnesses 
(unstarred in Figure 14) which are not known to affect autonomic function. 
One (25%) was taking a drug (propoxyphene) suspected to affect heart 
rate variability because of its similarity to morphine. 
These subjects did not differ in age (46), respiratory rate (12.5) 
or heart rate (81) from controls. 
Both short term and long term variability were less than controls, 
but with the small size of the patient group, the difference was not 
significant at the 5% confidence level. 
STV averaged 15 msec (p > .10) and STVi was 1.9% (p < .10). Three 
of the four (75%) showed "low" variability (p > .10). 
LTV averaged 6 bpm (p ^ .10) and LTVi was 7.9% (p ^ .10). 
All four patients performed square wave breathing, which elicited 
low maximal-long term variability: maxLTV 19.5 bpm (p <, .025), maxLTVi 
25.1% (p <. .02) . 
6. Miscellaneous patients 
In the process of searching for control subjects a recording was 
made on a 57-year old man with severe rheumatoid arthritis without other 
illnesses. His tracing was strikingly flat despite relatively low 
respiratory and heart rates (15 and 78, respectively). He had impotence 
but no other symptoms of dysautonomia. With the idea that rheumatoid 
arthritis interferes with autonomic function, perhaps by causing a 
vasculitis-induced neuropathy, other patients were sought with rheumatoid 
arthritis. Only two other subjects, however, could be studied in the 




Two patients with advanced cirrhosis but without other illness 
showed low variability; however, stastical analysis was deferred because 
of the small size of the patient group. They had an average STV of 2.5 
msec, STVi of 0.45%, LTV of 1 bpm, LTVi of 0.9%, maxLTV of 8 bpm, and 
maxLTVi of 7.4%. 
The abnormal appearance of several tracings called attention to 
previously un-noticed arrhythmias in several cases, including frequent 
unifocal premature ventricular contractions in an elderly man undergoing 
orthopedic surgery, a recurrence of atrial fibrillation in a dialysis 
patient, and recurrence of a multifocal atrial tachycardia in a man with 
acute decompensation of chronic obstructive pulmonary disease. These 
recordings had easily recognized and distinctive patterns. Two of them 
were available for illustration in Figure 15, along with a recording of 
multifocal premature contractions for comparison. 
Stress Tests 
Stress-tested subjects were referred for assistance in diagnosis of 
chest pain or for follow-up in the Cardiac Rehabilitation program. 
Twenty-four of the tests were "negative" and 17 were "positive" by ECG 
criteria. These two groups had comparable ages (50 and 54, respectively) 
and initial heart rates (93 and 86) but as would be expected, the nega¬ 
tive test subjects attained a higher peak heart rate (158 vs. 134) and 
workload (10.6 METS vs. 8.8 METS) than positive test subjects. Also as 
expected, a higher percentage of negative test subjects reached 90% 
predicted maximal heart rate (14 of 24, 58% vs. 1 of 17, 6%). Eight of 
the negative test-takers (33%) and 11 of the positive test-takers (65%) 
were taking possibly autonomic active drugs. 
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These recordings showed a variety of patterns. In particular, the 
apparent variability of the heart rate tended to change as the heart rate 
rose and fell with changing work loads. Typically the short term vari¬ 
ability would diminish and long term variability would disappear as 
exercise began and the heart rate began to rise (Figure 16). At peak 
heart rate, short term variability would remain unchanged, decrease, or 
even appear to increase (Figure 17) over baseline levels. Then, as heart 
rate fell with recovery, the appearance of baseline short term variability 
would begin to emerge, but at the same time there was frequently a period 
of exaggerated long-term variability (Figure 18), presumably during the 
hyperventilation that occurred with recovery (no recordings of respira¬ 
tion were available for this patient group). Examples were seen of every 
combination of the above-described changes in variability. The record¬ 
ings were studied with a view to determine whether any pattern of 
variability was more likely to occur in a positive or a negative test. 
The recordings were scored for the appearance of short term and 
long term variability at rest ("low" or "average") and for increases and 
decreases in both kinds of variability during exercise, at peak heart 
rate, and with recovery. The proportion of subjects in each of the two 
groups that demonstrated each characteristic was calculated. Positive 
and negative stress test recordings did not differ from each other at the 
5% level of confidence in any of these respects. 
The appearance of increased short term variability at peak heart 
rates was so unexpected and striking that it was tested to determine 
whether it was an artifact of recording at high heart rates or a pheno¬ 
menon occurring only in the few patients who attained maximum workloads. 
Presence of increased short term variability at peak did not correlate 

well with peak heart rate (r = .28, p < .10) or with METS attained 




Our study clearly demonstrates decreased RR variability in all the 
types of illness studied, including several that had not previously 
been examined. We have substantially expanded the documentation of low 
variability in some other patient groups. We have shown that low short 
term and low maximum-long term variability are present in heart disease 
patients in addition to confirming the low long term variability that 
had been reported, and have added 19 patients to the previous total of 
32 to have been examined for variability (21, 22). We have demonstrated 
that low long term and low maximum-long term variability occurs in 
hypertensives, and confirmed the low short term variability that was 
previously reported. We have contributed 13 hypertensive patients to 
the previous study of 15, and did so using a much larger sample of RR 
intervals per patient (14). This study also provides the first quantifi¬ 
cation of short term variability in diabetic patients, and shows it to 
be low in addition to confirming the low long term and maximum-long term 
variability previously reported (3, 45). 
Information about variability in uremic patients and patients with 
cirrhosis has not been previously reported. Although low variability in 




the first to show similar findings in conditions of respiratory distress 
in the adult. 
Methods 
Our methods of quantifying variability include some techniques new 
to the study of the adult that enhance reproducibility. 
One such departure from previous technique was our modification of 
variability data to a form corrected for heart rate. Whether or not 
this modification is a mandatory one is unclear from empirical observa¬ 
tions: short term variability has been reported not to depend on mean 
heart rate (27), as has long term variability in both normal adults (7, 
27) and diabetics (3, 33), but on the other hand diminished short term 
variability with higher heart rates was seen in our control group and 
by others (10). We do feel, however, that there is a logical argument 
for correcting for heart rate based on the following arithmetical con¬ 
siderations. 
An equal amplitude of variability in milliseconds does not produce 
equal proportional changes in RR interval at different heart rates. For 
example, a 250 msec decrease in RR interval starting at baseline rate of 
60/minute increases the rate to 80/minute. The same 250 msec decrease 
starting at a baseline rate of 120/minute would increase the heart rate 
to 240/minute, outside the physiological range of sinus rhythm in most 
adults. Whereas the first rate change is common in the course of long 
term cycles, the second is almost inconceivable. Consequently, comparing 
variability measured simply in terms of RR interval or heart rate differ¬ 
ences may distort comparisons between subjects with different heart 
rates: in our results, normalizing for baseline heart rates when 
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comparing patient variabilities with controls occasionally changed the 
p-value of the result markedly. For example, STV in heart disease 
patients only bordered on significant difference from controls (p < .10) 
while STVi was clearly significantly different from controls (p < .02). 
The variability pulse provided by the neonatal monitor automati¬ 
cally analyzed a large number of successive RR intervals that could be 
accumulated in less than ten minutes, in contrast to previous work on 
short term variability in adults that has been founded on as few as 10 
successive RR intervals (14) or has required long periods of recording 
and computer hardware (8, 27, 29, 37). The variability pulse has proved 
a more sensitive and reproducible measurement for low variability than 
scoring the appearance of the tracings. Visual assessment, however, 
provided three advantages: an estimate was possible with only one or 
two minutes of recording, it required no arithmetic manipulation, and 
ectopy could easily be ignored in the estimate. 
The combined quantification and comparison of short term, long 
term, and maximum-long term variability in the same subjects has not 
previously been reported. MaxLTVi consistently made the greatest dis¬ 
tinction between patients and controls; both maxLTV and maxLTVi were 
significantly lower than controls in all patient groups. STVi was more 
sensitive than STV in identifying abnormal subjects, and LTV was the 
least sensitive of all measures. That a respiratory-related arrhythmia 
is more sensitive than beat-to-beat variability to abnormal physiology 
is quite in line with observations by ourselves and others that respiratory- 
induced arrhythmia can disappear in situations where short-term variability 
is retained. Respiratory-induced variability is the last type of vari¬ 
ability to appear in the normal fetus (24) and apparently the first to 

44 
disappear in the diseased adult population. We found that measuring 
the maximized respiratory-induced arrhythmia provides the most reliable 
method of comparison between subjects since the respiratory rate is kept 
constant. 
In view of the above, we conclude that maxLTV is the most useful 
clinical index demonstrated by this study, providing a quick and sensi¬ 
tive estimate of abnormal regularization of heart rate. In addition to 
being the most sensitive it is the most convenient of the measures: it 
is elicited by square-wave breathing, a technique easily taught to all 
but the most dyspneic patients; and it can be measured with standard 
electrocardiographic equipment, as the shortest and longest RR intervals 
during respiratory cycles can be distinguished easily and measured with 
calipers. 
Normal Subjects 
Our findings in control subjects show somewhat lower short term 
variability than did Eckoldt (15): STV of 25 msec and STVi of 3.2% 
versus 37 msec and 4.5%. The three subjects' recordings with variability 
pulses exceeding the scale may account for part of the difference; the 
fact that our population averaged 20 years older than did Eckoldt's may 
also be a factor, though there has been no documentation of a relation¬ 
ship between STV and age. 
LTV in our control group also showed wide inter- and intra-subject 
variation (7). Our average LTV values was similar to those determined 
previously for the same age group (21) and was about half as large as 
that seen in younger men (11, 21). No standards for maxLTV during slow 
or deep breathing have been published, but the pattern we observed of 
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acceleration and deceleration with the respiratory cycle was similar to 
other descriptions (2, 7, 11, 12). 
The inverse correlation of STV and maxLTV with heart rate further 
encourages the use of the corresponding normalized indices for compara¬ 
tive studies. The relationship between variability and heart rate may 
be derived from an upper limit for rate in the sinus node, so that there 
is "less room" for variability at higher heart rates. The inverse 
association of LTV with respiratory rate is an expected finding (12), 
but the lack of a similar relationship to age is at variance with other 
reports (17, 21, 43). Our age range of subjects, however, was narrower 
than the subjects of other studies, which included children and young 
adults. 
Patient Groups 
In interpretation of our results from the disease groups, there are 
three caveats to be kept in mind. 
The nature of the hospital patient population made it difficult to 
find patients with only one, uncomplicated disease. Our disease groups 
are not "pure," and one must be cautious in attributing the cause of the 
diminished variability that we observed so frequently to the diseases 
named. In particular, the presumed presence of some degree of coronary 
artery disease in most of the diabetics, the likelihood of some degree 
of left ventricular hypertrophy in hypertensives, the frequency of 
congestive heart failure in dialysis patients, and the high incidence 
of hypertension in all patient groups, blurs the distinctions between 
patient groups. We have made an attempt to minimize this intergroup con¬ 
tamination with the data from the "disease alone" groups. In fact, the 

"disease alone" group data generally supported the results from their 
parent groups; though the numbers of recordings collected were small, 
the distinctions from the control subjects remained statistically signi¬ 
ficant in most cases. The "disease alone" subjects did have some other 
illness that might be suspected to affect variability, including obesity, 
cirrhosis, organic brain syndrome, and alcoholism, but the evidence that 
variability is affected in these illnesses (5, 21, 42) is suggestive at 
best. 
Secondly, most of the patients, except for those with only diabetes 
or renal failure, were taking medications with possible autonomic actions 
Since there has been no research regarding the effect of any drug other 
than atropine (11, 45) and propranolol (45) on the variability of adult 
heart rates, the category of drugs with "probable" or "suspected" auto¬ 
nomic actions was deliberately over-inclusive. For example, we included 
propranolol despite the fact that the previous study failed to show an 
effect on variability, because the number of subjects was small and the 
finding has not been confirmed. Our present information cannot predict 
whether the use of these drugs has lowered or raised the variability 
observed in each patient group as a whole. However, there is some circum 
stantial evidence that drug ingestion is not the major determinant of 
low variability: Hinkle et al.'s (22) population of middle aged men 
with low variability ("sustained relative bradycardia") did not include 
more than the expected frequency of men taking drugs which might affect 
the heart rate. 
Third, the respiratory rates of the patients were generally higher 
than controls, in several cases "significantly" higher using the t-test. 
This we would expect to reduce the average LTV and LTVi among patients 
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compared to controls, but should have had no effect on STV, STVi, 
maxLTV, or maxLTVi. 
Our finding of low short term, long term, and maximum-long term 
variability in diabetics agrees with the previous work (8, 11, 28, 45). 
The high proportion of our patients with neuropathies might have biassed 
the group as a whole toward low variability, but even the patients with¬ 
out clinical dysautonomia had regularized heart rates. The present and 
previous work suggest that diminished variability is a fairly sensitive 
indicator of autonomic neuropathy, since it was present in asymptomatic 
patients, but was more severe in symptomatic ones, and correlated better 
with presence of dysautonomia than with years of diabetes. 
Low short term and max-long term variabilities are new observations 
among patients with heart disease without clinical sinus node dysfunction. 
It is especially interesting to have found low variability among a sub¬ 
group of patients with predominantly left ventricular disease, those 
with atherosclerosis alone. Covert sinus node disease, as was suggested 
in the previous study of middle aged men and risk of heart disease (22), 
and/or diminished autonomic tone (13, 19), might account for some of the 
regularization of heart rate in our groups. 
The loss of variability in hypertensives was particularly striking: 
those with hypertension alone had almost the lowest short term variability 
of any group studied. It would be intriguing to learn whether this 
phenomenon simply illustrates a primary defect in baroreceptor control, 
or whether it represents a secondary effect of exposure of the organism 
to abnormal pressures. Variability did not vary inversely with length 
of exposure to hypertension or to degree of retinopathy in our group. 
• • 
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These findings suggest that low variability in this group is a primary 
rather than a secondary observation. Baroreceptor insensitivity would 
indeed interfere with the "resetting" of heart rate necessary for 
respiratory arrhythmia in Freyschuss and Melcher's model. On the other 
hand, it must be noted that Eckoldt did find a correlation between low 
variability and duration of hypertension (14). Loss of variability is 
seen so early in diabetics one wonders whether it also appears early in 
the course of hypertensive disease. It might actually predate the onset 
of sustained hypertension if it is as sensitive a marker for abnormal 
baroreceptor function as it is for autonomic neuropathy. Loss of vari¬ 
ability might therefore provide a convenient, indirect measure of baroreceptor 
function of potential use in the elucidation of the pathophysiology of 
essential hypertension. 
Among the respiratory distress patients there was not the consistent 
correlation between degree of hypoxia and regularization of heart rate 
that one might expect by analogy with the experience in neonates (24). 
It may be that a very wide range of p02 is required to demonstrate adult 
variability changes, especially in these severely ill patients, whose 
baseline variability was the lowest seen in any group. If hypoxemia was 
the cause of low variability in this group, reflexes originating in 
arterial chemoreceptors could be responsible for an inhibitory effect on 
autonomic responsiveness to physiological events that ordinarily 
engender changes in heart rate. 
The changes in variability seen in the respiratory distress patient 
on various types of respiratory assistance pertain to discussions in the 
literature regarding the role of medullary respiratory center activity 
in generating respiratory-related arrhythmia. The findings in our 
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patient would suggest not that mechanical ventilation suppresses vari¬ 
ability, as we had guessed might have happened, but that some medullary 
respiratory center activity is necessary for respiratory arrhythmia, 
such that the patient's optimum self-initiated respiratory rate for 
producing variability was greater than zero but less than the high 
respiratory rate which damps out cycles of arrhythmia. This observation 
of absent LTV when voluntary respiration is absent differs from that of 
Freyschuss and Melcher discussed earlier. Their experiment took place 
under more controlled conditions, but their subjects were less likely to 
have suppressed all voluntary breathing efforts than ours while on con¬ 
trolled ventilation. The question of the necessity of central nervous 
system input for respiratory sinus arrhythmia remains, therefore, 
unresolved. 
The observation that short and long term variability in the one 
patient who was studied while sleeping did not differ from that while 
awake differs from previous observations of lowered variability during 
sleep in normal subjects (30). Our patient, however, had sleep apnea 
with massive obesity, a syndrome which has been associated with marked 
sinus arrhythmia (> 30 bpm amplitude) during sleep in a recent study of 
15 patients (40). Sinus arrhythmia cycled with apnea-breathing cycles, 
and was clearly greater than the patients' waking amplitude of sinus 
arrhythmia. They frequently had "potentially life-threatening" brady- 
and tachyarrhythmias as well; all of the abnormal arrhythmias disappeared 
after therapeutic tracheostomy. In accordance with the previous discus¬ 
sion of the physiology of respiratory sinus arrhythmia, the patient who 
had autonomic dysfunction (Shy-Drager syndrome) along with sleep-apnea, 
and the other subjects when given atropine, showed a reduced amplitude 
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of the characteristic sinus arrhythmia. Our patient clinically 
resembled those of the previous study in many respects (obesity, day¬ 
time somnolence, loud snoring and 20 second periods of apnea during 
sleep, hypertension); it is unclear why he failed to exhibit the heart 
rate abnormalities that were termed a "hallmark" of sleep-apnea in the 
previous study, but is perhaps related to his drug use (alphamethyldopa) 
or to his chronic alcoholism. 
The reason for the appearance of diminished variability in the 
dialysis patients is obscure, as none of the subjects had clinical 
dysautonomia and the degree of variability loss did not correlate with 
length of chronic renal failure. 
Stress Test Subjects 
The large-amplitude LTV occasionally seen in the stress test record¬ 
ings is similar to that seen by Davies and Neilson (12) in normal 
subjects after exercise. We could not correlate the finding to workload 
capacity, however, as they correlated it to "fitness" and exercise train¬ 
ing. We did not find any evidence for the usefulness of variability 
assessment in interpreting either the attainment of submaximal workloads 
or the development of myocardial ischemia during treadmill testing. In 
general, other than the smooth rise in baseline heart rate, variability 
was nearly absent in most subjects during exercise. 
Although we could not distinguish what produced the increased short 
term variability that we observed occasionally during the stress tests, 
it is interesting that high beat-to-beat variability sometimes indicates 
abnormality in the fetus: it has been associated with fetal distress 
(6), hypercardia and hypoxemia in fetal animals (9), and administration 
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of magnesium sulfate (35) and of lidocaine paracervical block (32) to 




We have made an intriguing discovery of diminished heart rate vari¬ 
ability in a still broader range of illnesses than was previously known, 
and have documented its presence even in the absence of other evidence 
for dysautonomia or sinus node disease. The factors accountable for 
this regularization of heart rate probably vary from one condition to 
another, as it is seen in such a variety of situations. The prevalence 
of low variability indicates that altered sensitivity of autonomic 
homeostatic mechanisms is a frequent concomitant of systemic illness. 
Despite our failure to uncover a relationship between duration or 
severity of disease and diminished variability in the hypertensives and 
dialysis patients, we did obtain evidence from other groups that vari¬ 
ability diminishes with increasing severity of disease. Previous 
investigators have shorn a relationship between variability and neuro¬ 
logical function in acute central nervous system disease (30). In our 
study the following relationships held: 
1. Amplitude of heart rate changes were inversely associated with 
severity of dysautonomia in diabetics and with functional class in heart 
disease patients. 
2. Patients with a combination of diseases had lower variability 
than patients with a single disease. 




those with respiratory distress. 
We did not find, as did Vallbona (42) in neurological patients, that a 
"flat" heart rate tracing carried the ominous implication of imminent 
death, since such tracings were observed in several ambulatory, well 
compensated cardiac patients. 
We have determined that diminished variability in most subjects 
can be quickly and conveniently identified by measuring the maximum 
amplitude of cyclic change in heart rate during a technique of exag¬ 
gerated breathing called "square wave breathing." For those subjects 
who are severely dyspneic or unable to understand instructions, the 
most sensitive measure consists of the average beat-to-beat variation 
in RR interval length, which can be provided by the "variability pulse" 
from a neonatal monitor. We have presented evidence that intersubject 
comparisons of any measure of variability are made more accurate by 
normalizing the variability for the mean heart rate of the subject. 
Variability can also be estimated by examination of the appearance of 
instantaneous heart rate recordings. 
We suggest that variability monitoring provides a simple tool which 
can be used to advance understanding of physiological, and especially 
autonomic, responses to pathological states. Studying heart rate vari¬ 
ability might facilitate the diagnosis of dysautonomia; it might document 
the progression of autonomic neuropathy in diabetics; or it might provide 
an indirect test of baroreceptor function in the onset and progression 
of idiopathic hypertension. With additional investigation, perhaps this 
inexpensive, rapid and noninvasive procedure will also prove useful as a 
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Figure X: Recording from 60 year old man with diabetic 
autonomic neurqpathy, respiratory rate 14, showing a small 
amount of short term variability despite total absence of 
long term variability* 
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Figure 3: Classification of Medications Taken by Subjects 
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Figure 9: Characteristics of Diabetic Patients (N = 15) 
Duration of Diabetes N 
<£ 5 years 1 
5-9 years 5 
10-14 years 5 
15-19 years 3 
^ 20 years 1 
Treatment N 
Diet alone 2 
Oral hypoglycemics 4 
16-35u NPH insulin qd 4 
36-55u NPH insulin qd 3 
& 56u NPH insulin qd 2 
Complications of Diabetes N 
Dysautonomia 6 
Motor/sensory neuropathy 10 




Anemia, -'hereditary spherocytosis 
undiagnosed cause 
^Atherosclerotic heart disease, with history of: 
angina 
congestive heart failure 
myocardial infarction 
congestive heart failure and myocardial infarction 
Atherosclerotic peripheral vascular disease 
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Figure 11: Characteristics of Heart Disease Patients (N = 19) 
Etiology N 
Alcoholic myopathy 1 
Arteriosclerosis 15 
Cor pulmonale 1 
Hypertension 1 
Idiopathic 1 




Myocardial infarction, recent (* *<1 month) 
old 
Pericardial disease (recurrent effusions) 





Antiarrhythmic medication required 
Conduction defects on ECG (1° A-V block; IVCD) 
Congestive heart failure 
Functional Class 
I Symptoms occur with heavy exertion only 
II Symptoms occur with moderate exertion 
III Symptoms occur with light exertion 




Anemia, undiagnosed cause 
Atherosclerotic peripheral vascular disease 
Bronchitis (day 4 of antibiosis, asymptomatic) 





-'Orthostatic, hypotension, undiagnosed cause 
-'Psychiatric, disorder (depression) 
*Rheumatoid arthritis 


































^Patients excluded from "Atherosclerotic Heart Disease Only" group 
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Figure 12: Characteristics of Hypertensive Patients (N = 13) 
Time Since Diagnosis Was Made .N 
5 years 5 
5-10 years 3 
11-15 years 1 
16-20 years 0 
> 20 years 4 
Duration of Treatment N 
None 6 
Intermittent 6 
Continuous since diagnosis 1 
Complications of Hypertension N 






no retinal exam 4 
Clinical cardiac disease (LVH, CHF, 5 




*Atherosclerotic heart disease with history of: 
Congestive heart failure 
Myocardial infarction 
Past history of nodal rhythm, spontaneously 
reverting to sinus rhythm 
*Chronic obstructive pulmonary disease 
Colitis 
^Diabetes (diet control) 
Hyperuricemia/gout 
Manic-depressive psychosis 














^Patients excluded from "Hypertension Alone" group 
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Figure 13: Characteristics of Respiratory Distress Patients (N = 8) 
Cause of Respiratory Distress N 
Adult respiratory distress syndrome 1+ 
Aspiration pneumonia 1 
Bronchospasm Id- 
Chronic obstructive pulmonary disease 
stable 1 
with acute decompensation 2 
with acute congestive heart failure 1 
with penumonia 1 
Hydrothorax/ascites 1+ 
Sleep-apnea syndrome/obesity 1 
Blood Gases at Time of Tracing 
N 
pH 7.36-40 T 
7.41-45 3 
7.46-50 2 








Ventilatory Assistance N 
Mechanical ventilator 3 
Spontaneous respiration with added 0? 2 




^Congestive heart failure, past history of 





*Laennec's cirrhosis with encephalopathy, 
renal insufficiency, and acidosis 
-'Massive obesity 
^Peritonitis (Eh coli) 
*Psychiatric disorder (manic-depressive psychosis) 
‘-''Recent cardiac arrest 2° to aspiration 
(2 days prior to tracing) 
*Recent seizure, undiagnosed cause 


















*Patients■excluded from "Respiratory Distress Alone" group 
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Figure 14: Characteristics of Patients on Dialysis (N = 18) 
Causes of Renal Failure N 
Diabetes 1 
Heroin abuse 1 
Hypertension 5 
Interstitial nephritis 2 
Membrano-proliferative glomerulonephritis 3 
Multiple myeloma 1 
Polycystic kidney disease 3 
Unknown 1 
Time on Chronic Dialysis N 
< 1 year 3 
1-5 years 7 
> 5 years 8 
Progress of Treatment When Recording Began N 
0-2 hours 5 
2-4 hours 8 
4-6 hours 3 
Associated Diseases 
Adrenal insufficiency (surgically induced) 
'“Alcoholism 
*Chronic obstructive pulmonary disease 
'“'Constrictive lesion transverse colon, workup pending 
^Diabetes mellitus 
*Digital clubbing, unknown cause 
*Fever of unknown origin, resolved one week after 
recording was made 
*Heart disease: 
Angina 
Congestive heart failure 
Left ventricular hypertrophy with strain 
Previous history of arrhythmia (atrial flutter) 




Multiple duodenal ulcers 
Multiple myeloma 
'“Organic brain syndrome 







































Figure 16; Portions of a stress test showing diminished short 








Figure 37: Portions of a stress test showing increased short 
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Figure 181 Portions of a stress test showing increased 
long term variability during recovery. 
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